《精准医药在肿瘤学中的应用》网络研讨会系列

Driven by the increased emphasis on precision and personalized approaches to drug development, Covance will be delivering a webinar series to look at specific challenges and opportunities with current and future applications in oncology.

The series kicks off with a view of trends in immunotherapies including preclinical model selection, biomarkers of safety and efficacy, and specific trial design and medical monitoring considerations.

Other topics will delve into:

  • Adoptive T-cell therapies, addressing safety assessment and monitoring tools from preclinical through clinical development 
  • Considerations for clinical trial design and execution for novel targeted therapies and immunotherapies
  • Biomarker technologies for the detection of rare cancer driver mutations and novel targeted therapies
  • Applications for liquid biopsy technologies

We look forward to seeing you in one or all of these webinars - in the live sessions or on demand.

Now Available On-Demand

  • 了解过继性T细胞疗法的发展简史

  • 获得评估安全性和潜在​​功效的策略,以通过法规流程,从而进入临床

  • 了解用于评估和监测治疗剂量的药代动力学、靶细胞群水平以及其他监测疗效的生物标记物的作用

  • 听取有关潜在毒性评估和管理的最新准则

主讲人:

Brian E. McIntosh, PhD
Study Director and Scientific Lead, Cell, Gene and Regenerative Therapies, Covance

Akanksha Gupta,博士 
Head, Immunology, Biomarker Solution Center, Covance

Carlo Lanza, MD, PhD
Executive Medical Officer, Covance and Subject Matter Expert in Hematology Oncology

Preclinical Pharmacology, Toxicology & Pharmacokinetics 
Thursday, 18 June 2020, 10:00 am EDT/3:00 pm BST

In this webinar, attendees will learn about and understand

  • In vitro verification of product function
  • 临床前研究中的动物模型选择
  • 药理学和毒性研究,以指导生物学相关和临床安全剂量水平的确定
  • 产品的生物学特性包括肿瘤细胞浸润、持续存在性和病毒脱落

主讲人:

Maryland Franklin, PhD
Executive Director of Scientific Development, Preclinical Oncology

Brian E. McIntosh, PhD

Study Director and Scientific Lead Cell, Gene and Regenerative Therapies